RPF2 mediates the CARM1‑MYCN axis to promote chemotherapy resistance in colorectal cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RPF2 mediates the CARM1‑MYCN axis to promote chemotherapy resistance in colorectal cancer cells

Published:2023-11-21 Issue:1 Volume:51 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Lu Macheng¹,Hu Xingqian¹,Cheng Cong¹,Zhang Yuan¹,Huang Longchang²,Kong Xiangpeng¹,Li Zengyao¹,Zhang Qiuhua³,Zhang Ye¹

Affiliation:

1. Department of General Surgery, Nanjing Medical University Affiliated Wuxi People's Hospital, Wuxi, Jiangsu 214023, P.R. China

2. Department of General Surgery, Affiliated Jinling Hospital, Medical School of Nanjing University, Xuanwu, Nanjing, Jiangsu 210093, P.R. China

3. Department of Nephrology, The Wuxi No. 2 People's Hospital, Wuxi, Jiangsu 214023, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference36 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

2. Colorectal cancer;Dekker;Lancet,2019

3. Coupling of 5S RNP rotation with maturation of functional centers during large ribosomal subunit assembly;Micic;Nat Commun,2020

4. Structure of nascent 5S RNPs at the crossroad between ribosome assembly and MDM2-p53 pathways;Castillo Duque de Estrada;Nat Struct Mol Biol,2023

5. Ribosome production factor 2 homolog promotes migration and invasion of colorectal cancer cells by inducing epithelial-mesenchymal transition via AKT/Gsk-3β signaling pathway;Li;Biochem Biophys Res Commun,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resting CD4 regulatory T cell and neuroblastoma: A Mendelian randomization study;Pediatric Discovery;2024-06

2. Research Progress on CARM1 and its Relationship with Colorectal Cancer;Cancer Investigation;2024-05-27

3. Structure-based discovery of potent CARM1 inhibitors for colorectal cancer therapy;European Journal of Medicinal Chemistry;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3